New evidence in oncologic and cardiocirculatory medicine.
Conti
Andrea Alberto
AA
Department of Critical Care Medicine and Surgery, University of Florence and Don Carlo Gnocchi Foundation, IRCCS Florence, Viale Morgagni 85, 50134, Florence, Italy. aa.conti@dac.unifi.it
Dilaghi
Beatrice
B
Modesti
Pietro Amedeo
PA
Nozzoli
Carlo
C
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D001943:Breast Neoplasms / Q000175:diagnosis; D002309:Cardiology; D003936:Diagnosis, Computer-Assisted; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008327:Mammography; D008495:Medical Oncology; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D018931:Antineoplastic Agents, Hormonal; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D008558:Melphalan; D011241:Prednisone